Complete replication of human sperm genome in egg extracts from Xenopus laevis. 1998

Y S Xu, and W R Overton, and J L Marmar, and J C Leonard, and J P McCoy, and G H Butler, and H Li
Coriell Institute for Medical Research, Camden, New Jersey 08103, USA.

To examine the ability of Xenopus egg extracts to support a complete replication cycle of human sperm genome, demembranated human spermatozoa were incubated with the extract from activated Xenopus laevis eggs. Most sperm heads were decondensed within 15 min. The heads became round within 30 min with diameters of 10-30 microns. The process of DNA replication in the pronuclei was monitored by two methods, bromodeoxyuridine incorporation and flow cytometry. The results indicate that DNA replication was initiated approximately 1.5 h after membrane structure formation and that it lasted up to 9 h. The amounts of DNA in most pronuclei were doubled by 4-9 h, depending on which donor toad was the source of the egg extract. Inclusion of the protein synthesis inhibitor, cycloheximide (100 micrograms/ml), had no obvious effect on human sperm DNA replication but appeared to prevent the pronuclei from degradation after a prolonged period (> 6 h) of incubation. After storage in liquid nitrogen for > 1.5 mo, the efficiency of the egg extracts in supporting sperm head decondensation and DNA replication was reduced for human sperm but not for Xenopus sperm. Possible applications of the use of Xenopus egg extract for human sperm activation and DNA replication are discussed.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D011500 Protein Synthesis Inhibitors Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. Protein Synthesis Antagonist,Protein Synthesis Antagonists,Protein Synthesis Inhibitor,Antagonist, Protein Synthesis,Antagonists, Protein Synthesis,Inhibitor, Protein Synthesis,Inhibitors, Protein Synthesis,Synthesis Antagonist, Protein,Synthesis Inhibitor, Protein
D001973 Bromodeoxyuridine A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. BUdR,BrdU,Bromouracil Deoxyriboside,Broxuridine,5-Bromo-2'-deoxyuridine,5-Bromodeoxyuridine,NSC-38297,5 Bromo 2' deoxyuridine,5 Bromodeoxyuridine,Deoxyriboside, Bromouracil
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Y S Xu, and W R Overton, and J L Marmar, and J C Leonard, and J P McCoy, and G H Butler, and H Li
October 1999, Biology of reproduction,
Y S Xu, and W R Overton, and J L Marmar, and J C Leonard, and J P McCoy, and G H Butler, and H Li
December 2002, Science in China. Series C, Life sciences,
Y S Xu, and W R Overton, and J L Marmar, and J C Leonard, and J P McCoy, and G H Butler, and H Li
January 1991, Methods in cell biology,
Y S Xu, and W R Overton, and J L Marmar, and J C Leonard, and J P McCoy, and G H Butler, and H Li
May 1987, The Journal of experimental zoology,
Y S Xu, and W R Overton, and J L Marmar, and J C Leonard, and J P McCoy, and G H Butler, and H Li
December 2005, The Journal of cell biology,
Y S Xu, and W R Overton, and J L Marmar, and J C Leonard, and J P McCoy, and G H Butler, and H Li
January 2000, Methods in enzymology,
Y S Xu, and W R Overton, and J L Marmar, and J C Leonard, and J P McCoy, and G H Butler, and H Li
August 2008, Journal of visualized experiments : JoVE,
Y S Xu, and W R Overton, and J L Marmar, and J C Leonard, and J P McCoy, and G H Butler, and H Li
August 1981, Nucleic acids research,
Y S Xu, and W R Overton, and J L Marmar, and J C Leonard, and J P McCoy, and G H Butler, and H Li
January 2016, Methods in molecular biology (Clifton, N.J.),
Y S Xu, and W R Overton, and J L Marmar, and J C Leonard, and J P McCoy, and G H Butler, and H Li
September 2018, Cold Spring Harbor protocols,
Copied contents to your clipboard!